InsidersTradesSigma
Follow the 씨엑스아이 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 씨엑스아이 has logged 6 public disclosures. Market capitalisation: €32.8bn. The latest transaction was reported on 17 June 2026 (Purchase). Among the most active insiders: LIN JINSHENG. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
씨엑스아이是一家在XKRX市场上市的医疗保健和制药领域的公司。